Mamento, Hanan S.
HRN: 11-46-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
CEFUROXIME 500MG (TAB)
07/10/2022
07/16/2022
PO
500mg
BID
S/P NSVD Non Institutional Delivery
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes